Changes in the nuclear levels of TDP-43 in the endothelium are sufficient to drive many of the transcriptional alterations observed in the REV1 population of capillary ECs, strongly suggesting that a disease-specific loss of nuclear TDP-43 from ECs drives loss of BBB integrity observed in AD, ALS and FTD. This evidence concerns the gene TARDBP and Alzheimer disease.